NPS Pharmaceuticals Inc (NPSP)

45.97
0.01 0.02
Prev Close 45.96
Open 45.96
Day Low/High 45.95 / 45.99
52 Wk Low/High 22.11 / 46.01
Volume 9.49M
Avg Volume 4.75M
Exchange
Shares Outstanding 108.58M
Market Cap 4.99B
EPS -0.08
Div & Yield N.A. (N.A)

Booking Some Pharma Profit

A bump from Morgan Stanley gives us a window to sell some shares.

Stocks Under $10 Weekly Summary

It was a quiet week for the model portfolio as stocks limped into the end of the third quarter.

Stocks Under $10: Blossoming Biotech Play

Stocks Under $10: Blossoming Biotech Play

Portfolio manager David Peltier discusses a hot biotech stock with a promising clinical pipeline.

Stocks Under $10 Weekly Summary

We did not make any trades in the model portfolio this week, but we did start building a watch list for potential new names.

3 Stocks Under $10 Moving Higher

3 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Cramer's 'Mad Money' Recap: When Progress Isn't Good

Cramer's 'Mad Money' Recap: When Progress Isn't Good

When it comes to high-frequency trading, individuals have no idea what they're up against, Cramer said.

Stocks Under $10 Weekly Summary

We took advantage of the market's strength this week to pocket some profits in three of our model portfolio positions.

NPS Pharmaceuticals To Present At UBS Global Life Sciences Conference

NPS Pharmaceuticals To Present At UBS Global Life Sciences Conference

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the UBS Global Life Sciences Conference in New York on Wednesday, September 19, 2012 at 9:00 a.

NPS Pharmaceuticals' CEO Presents At Morgan Stanley Global Healthcare Conference (Transcript)

NPS Pharmaceuticals' CEO Presents At Morgan Stanley Global Healthcare Conference (Transcript)

NPS Pharmaceuticals' CEO Presents at Morgan Stanley Global Healthcare Conference (Transcript)

Stocks Under $10 Weekly Summary

We used the market's strength this week to take some profits off the table in two model portfolio positions.

NPS Pharmaceuticals To Present At Upcoming Conferences

NPS Pharmaceuticals To Present At Upcoming Conferences

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is scheduled to present at the Morgan Stanley Global Healthcare Conference in New York on Wednesday, September 12, 2012 at 1:00 p.

Stocks Under $10: A Minor Setback

The FDA asked that this company modify the instructions for a treatment.

NPS Pharmaceuticals Expects To File Natpara™ BLA In Mid-2013

NPS Pharmaceuticals Expects To File Natpara™ BLA In Mid-2013

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today that it expects to submit its Biologic License...

Http://www.takeda.com (Graphic: Business Wire)

Http://www.takeda.com (Graphic: Business Wire)

Takeda Pharmaceutical Company Limited (TSE:4502, “Takeda”) and NPS Pharmaceuticals, Inc.

Stocks Under $10 Weekly Summary

We made no changes to the model portfolio during this slow pre-Labor Day week, but we continue to look for opportunities.

NPS Pharmaceuticals To Present At Stifel Nicolaus Healthcare Conference

NPS Pharmaceuticals To Present At Stifel Nicolaus Healthcare Conference

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Stifel Nicolaus Annual Healthcare Conference in Boston on Thursday, September 6, 2012 at 8:35 a.

Stocks Under $10 Weekly Summary

We pared down a chipmaker on strength this week, and we'll stay vigilant for buying opportunities for the model portfolio.

NPS Pharmaceuticals Receives Notice From FDA Of Advisory Committee Meeting For Gattex® (teduglutide)

NPS Pharmaceuticals Receives Notice From FDA Of Advisory Committee Meeting For Gattex® (teduglutide)

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced that the U.

Stocks Under $10 Weekly Summary

During a sleepy week of trading, we noticed an increase in insider buying and added shares to one model portfolio name.

NPS Pharmaceuticals' CEO Presents At Canaccord Genuity 32nd Annual Growth Conference (Transcript)

NPS Pharmaceuticals' CEO Presents At Canaccord Genuity 32nd Annual Growth Conference (Transcript)

NPS Pharmaceuticals' CEO Presents at Canaccord Genuity 32nd Annual Growth Conference (Transcript)

NPS Pharmaceuticals Announces Extension Of Action Date For Gattex® NDA To December 30, 2012

NPS Pharmaceuticals Announces Extension Of Action Date For Gattex® NDA To December 30, 2012

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has received a communication from the U.

Stocks Under $10 Weekly Summary

As earnings season began to wind down this week, we used a selloff in one model portfolio name to add to our position.

NPS Pharmaceuticals To Present At Upcoming Conferences

NPS Pharmaceuticals To Present At Upcoming Conferences

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is scheduled to present at the Canaccord Genuity Annual Growth Conference in Boston on Tuesday, August 14, 2012 at 8:30 a.

NPS Pharmaceuticals Joins The Oley Foundation In Recognizing HPN Awareness Week, August 5-11

NPS Pharmaceuticals Joins The Oley Foundation In Recognizing HPN Awareness Week, August 5-11

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced its support for the Oley Foundation’s...

Stocks Under $10 Weekly Summary

Stocks finished the week lower despite a big rally Friday, so we added to four positions in the portfolio on the volatility.

Building Up a Pharmaceutical Position

Despite posting positive second-quarter numbers, this name is trading lower today, so we're using the weakness to add shares.

NPS Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript

NPS Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript

NPS Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript

NPS Pharmaceuticals Reports Second Quarter 2012 Financial Results

NPS Pharmaceuticals Reports Second Quarter 2012 Financial Results

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today reported its results for the second quarter of 2012.

Previewing a Pharmaceutical Name

On the call, we'll be listening for more details about the two drugs the company has up for potential FDA approval.

Stocks Under $10 Weekly Summary

We used the volatility this week to add to two of our model portfolio positions.